1. Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive;Maciulaitis;Mol Ther,2012
2. Premarket Approval (PMA). Apligraf (Graftskin). Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=13855. Accessed August 8, 2012.
3. USP. Graftskin Monograph, http://www.pharmacopeia.cn/v29240/usp29nf24s0_m35846.html. Accessed August 8, 2012.
4. PAS 93: 2011. BSI. Characterization of human cells for clinical applications—guide. Available at: http://feedback.bsigroup.com/Home/Details/850. Accessed August 8, 2012.
5. “Hard cell” potency testing for cellular therapy products;Pritchett;BioProcess Int,2012